OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30069958

Weihai Guangwei Composites Co Ltd

Commodity ChemicalsVerified

Weihai Guangwei Composites maintains a conservative capital structure, with a debt-to-equity ratio of 0.3, indicating limited leverage relative to equity. The company’s liquidity position is characterized as medium, with a current ratio of 1.83, suggesting it can cover short-term obligations but with limited excess cash. Free cash flow is negative at -204.6 million CNY, driven by capital expenditures of -747.3 million CNY, which may signal ongoing investment in operational capacity. Profitability metrics show a return on equity (ROE) of 10.61% and a return on assets (ROA) of 6.69%, both above the typical thresholds for the Commodity Chemicals industry. Gross profit of 1.1 billion CNY and operating income of 708.5 million CNY reflect strong cost control and pricing power in its core markets. The company’s revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of segmentation increases exposure to regional demand fluctuations and supply chain disruptions. No material geographic breakdown is available in the latest financials. Growth expectations for the current fiscal year are modest, with no disclosed revenue acceleration in the outlook. Capital expenditures remain high, suggesting the company is investing in long-term capacity expansion. However, free cash flow remains negative, which may limit near-term reinvestment or shareholder returns. Risk factors include medium liquidity risk due to negative net cash after subtracting total debt, and a low dilution risk as shares outstanding remain unchanged between basic and diluted measures. No recent dilutive events are disclosed, and the company has not issued new shares in the latest reporting period. Recent filings and transcripts do not indicate material changes in strategy or operations. Analysts maintain a cautiously optimistic stance, with a mean recommendation of 1.50 (strong buy to hold) and a mean price target of 38.17 CNY, suggesting limited upside from current levels.

30-day price · 300699+0.09 (+0.3%)
Low$32.14High$37.32Close$33.20As of21 May, 00:00 UTC
Profile
CompanyWeihai Guangwei Composites Co Ltd
Ticker300699.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Weihai Guangwei Composites Co Ltd produces and sells composite materials, primarily serving the chemical industry, and generates revenue through the sale of these materials to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Weihai Guangwei Composites maintains a conservative capital structure, with a debt-to-equity ratio of 0.3, indicating limited leverage relative to equity. The company’s liquidity position is characterized as medium, with a current ratio of 1.83, suggesting it can cover short-term obligations but with limited excess cash. Free cash flow is negative at -204.6 million CNY, driven by capital expenditures of -747.3 million CNY, which may signal ongoing investment in operational capacity. Profitability metrics show a return on equity (ROE) of 10.61% and a return on assets (ROA) of 6.69%, both above the typical thresholds for the Commodity Chemicals industry. Gross profit of 1.1 billion CNY and operating income of 708.5 million CNY reflect strong cost control and pricing power in its core markets. The company’s revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of segmentation increases exposure to regional demand fluctuations and supply chain disruptions. No material geographic breakdown is available in the latest financials. Growth expectations for the current fiscal year are modest, with no disclosed revenue acceleration in the outlook. Capital expenditures remain high, suggesting the company is investing in long-term capacity expansion. However, free cash flow remains negative, which may limit near-term reinvestment or shareholder returns. Risk factors include medium liquidity risk due to negative net cash after subtracting total debt, and a low dilution risk as shares outstanding remain unchanged between basic and diluted measures. No recent dilutive events are disclosed, and the company has not issued new shares in the latest reporting period. Recent filings and transcripts do not indicate material changes in strategy or operations. Analysts maintain a cautiously optimistic stance, with a mean recommendation of 1.50 (strong buy to hold) and a mean price target of 38.17 CNY, suggesting limited upside from current levels.
Key takeaways
  • The company maintains a strong ROE and ROA, indicating efficient use of equity and assets.
  • High capital expenditures suggest ongoing investment in operational capacity.
  • Free cash flow remains negative, limiting flexibility for dividends or buybacks.
  • Analysts project limited upside, with a mean price target of 38.17 CNY.
  • Revenue concentration in a single segment increases exposure to market volatility.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.86B
Gross profit$1.10B
Operating income$708.5M
Net income$603.4M
R&D
SG&A
D&A
SBC
Operating cash flow$1.29B
CapEx-$747.3M
Free cash flow-$204.6M
Total assets$9.02B
Total liabilities$3.33B
Total equity$5.69B
Cash & equivalents
Long-term debt$1.70B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$5.69B
Net cash-$1.70B
Current ratio1.8
Debt/Equity0.3
ROA6.7%
ROE10.6%
Cash conversion2.1%
CapEx/Revenue-26.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300699Activity
Op margin24.8%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin21.1%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin38.5%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-26.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity30.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target38.17 CNY
Median price target38.00 CNY
High price target40.50 CNY
Low price target36.00 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count1.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.08 CNY
Last actual EPS0.73 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 04:31 UTCJob: 1073559a